Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00005061 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: bevacizumab

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC